drugset / Trial / NCT00101452

Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression

NCT00101452

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of s-adenosyl-l-methionine (SAMe) in treating major depression.

Timeline

Start
2005-04
Primary completion
2010-06
Completion
2010-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ademetionine Unknown 1600 mg
Subject Ademetionine Unknown 3200 mg
Comparator Escitalopram Small molecule 10 mg
Comparator Escitalopram Small molecule 20 mg